Bayer Kogenate FS

Attention: Your browser does not support Javascript, or Javascript support has been disabled. This web site utilizes the latest Internet technology, and in order to experience the full functionality of this web site you will need to ensure that Javascript is enabled.






























	General Conditions of Use Privacy Statement Imprint

	This website is intended for U.S. Audiences Only.

	© 2008 Bayer HealthCare LLC BAYER, the Bayer Cross, and Kogenate are registered trademarks of Bayer BIO-SET is a trademark of Biodome SAS

Kogenate^® FS, Antihemophilic Factor (Recombinant), Formulated with Sucrose

In the early 1970s, Bayer HealthCare introduced its first Factor VIII (FVIII) concentrate. Since then, we have dedicated ourselves to advancing the safety and efficacy of the factor VIII treatment we manufacture for patients with hemophilia A. We have also strived and continue to provide the bleeding disorders community with the tools, associated support programs, and resources that can facilitate an improvement in the quality of life for those patients.

We hope the information contained within this website addresses many of the questions that you might have regarding this treatment option, our electronic patient diary, our patient support programs and education materials, or any other resources that Bayer HealthCare provides.

However, if you have a specific technical or clinical question concerning Kogenate® FS, please contact Bayer Clinical Communications at 1-800-288-8371 or use our Contact Us form.

For all other questions, please contact Bayer Customer Service at 1-888-606-3780.

In the News
Here we post the latest news and press releases to keep you up to date.

Join Now!
Join our mailing list. It's simple and fast.
Join Now

Kogenate® FS, Antihemophilic Factor (Recombinant), is a recombinant factor VIII treatment indicated for the treatment of hemophilia A. The most frequently reported adverse events were local injection site reactions, dizziness, and rash. Known intolerance or allergic reactions to constituents of the preparation is a contraindication to the use of Kogenate® FS. Known hypersensitivity to mouse or hamster protein may be a contraindication to the use of Kogenate® FS. For important safety and use information, please see the full prescribing information.

Please consult your health care provider prior to making any lifestyle changes. The images used on this site do not necessarily represent actual Hemophilia patients.